The annual meeting of the Society for Imaging Informatics in Medicine convened in Portland, Oregon, with members of radiology’s imaging IT community joining together to discuss the latest trends in enterprise imaging, AI, and more.
As with other recent radiology meetings, AI dominated the discussion at SIIM 2025. But AI’s potential to revolutionize radiology has been tempered by nagging concerns about slow clinical adoption and questionable return on investment for healthcare providers.
Regulatory turbulence is also a concern, highlighted by recent changes implemented by the Trump Administration at the FDA. Some industry observers have speculated that AI approvals have slowed down, while others point out that the FDA – which has lagged other countries in approving new AI algorithms – perhaps might benefit from a fresh approach in how it regulates AI.
The Takeaway
In the end, SIIM 2025 can be chalked up as another success for the organization. While attendance seemed to be down slightly (most likely due to the West Coast location and pre-Memorial Day timing), the society pointed out that the number of vendor exhibitors at SIIM 2025 exceeded 100 for the first time in years – a sure sign of a healthy imaging IT industry.
Check out our SIIM 2025 videos below or visit the Shows page on our website, as well as our YouTube and LinkedIn pages, and keep an eye out for our next Imaging Wire newsletter on Thursday.
